Search research articles
Contact Us
Filters
Showing results (761-770 of 925) with videos related to
Page
of 93
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Seminars in Oncology
|
December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
M Markman, T Hakes, B Reichman, et al.
Journal of Cancer Research and Clinical Oncology
|
January 11, 1992
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy
M Markman, B Reichman, T Hakes, et al.
Journal of Cancer Research and Clinical Oncology
|
January 11, 1992
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer
M Markman, T Hakes, B Reichman, et al.
Cancer
|
January 15, 1993
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience
M Markman, J L Lewis, P Saigo, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy
M Markman, L C DeMarco, M Birkhofer, et al.
Journal of Clinical Ultrasound : JCU
|
August 1, 1980
Analysis of biparietal diameter as an accurate indicator of gestational age
A B Kurtz, R J Wapner, R J Kurtz, et al.
Gynecologic Oncology
|
July 1, 1993
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study
M Markman, E Rowinsky, T Hakes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer
M Markman, P Francis, E Rowinsky, et al.
Page
of 93
Search research articles
Search
Showing results (761-770 of 925) with videos related to
Sort By:
Page
of 93
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Seminars in Oncology
|
December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
M Markman, T Hakes, B Reichman, et al.
Journal of Cancer Research and Clinical Oncology
|
January 11, 1992
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy
M Markman, B Reichman, T Hakes, et al.
Journal of Cancer Research and Clinical Oncology
|
January 11, 1992
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer
M Markman, T Hakes, B Reichman, et al.
Cancer
|
January 15, 1993
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience
M Markman, J L Lewis, P Saigo, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy
M Markman, L C DeMarco, M Birkhofer, et al.
Journal of Clinical Ultrasound : JCU
|
August 1, 1980
Analysis of biparietal diameter as an accurate indicator of gestational age
A B Kurtz, R J Wapner, R J Kurtz, et al.
Gynecologic Oncology
|
July 1, 1993
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study
M Markman, E Rowinsky, T Hakes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer
M Markman, P Francis, E Rowinsky, et al.
Page
of 93